By Vineet Kumar 
Indian pharmaceutical giant Divi’s Labs’ on November 9 reported net profit at Rs 510 crore, up 46.5 percent for the second quarter of financial year 2024-2025 (Q2FY25). It reported net profit of Rs 348 crore in Q2FY24.
It reported revenue at Rs 2338 crore, up 22 percent.
The pharma major’s EBITDA rose almost 50 percent to Rs 716 crore.